KK-4277
- Generic Name
- KK-4277
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus
Phase 1
Recruiting
- Conditions
- Healthy VolunteersSystemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 116
- Registration Number
- NCT05411016
- Locations
- 🇯🇵
Fujita Health University Hospital, Kutsukake, Aichi, Japan
🇯🇵Japan Community Health care Organization Chukyo Hospital, Minami, Aichi, Japan
🇯🇵Juntendo University Urayasu Hospital, Urayasu, Chiba, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath